| Literature DB >> 11020288 |
M E Duggan1, L T Duong, J E Fisher, T G Hamill, W F Hoffman, J R Huff, N C Ihle, C T Leu, R M Nagy, J J Perkins, S B Rodan, G Wesolowski, D B Whitman, A E Zartman, G A Rodan, G D Hartman.
Abstract
Modification of the potent fibrinogen receptor (alpha(IIb)beta(3)) antagonist 1 generated compounds with high affinity for the vitronectin receptor alpha(v)beta(3). Sequential modification of the basic N-terminus of 1 led to the identification of the 5,6,7, 8-tetrahydro[1,8]naphthyridine moiety (THN) as a lipophilic, moderately basic N-terminus that provides molecules with excellent potency and selectivity for the integrin receptor alpha(v)beta(3). The THN-containing analogue 5 is a potent inhibitor of bone resorption in vitro and in vivo. In addition, the identification of a novel, nonpeptide radioligand with high affinity to alpha(v)beta(3) is also reported.Entities:
Mesh：
Substances：
Year: 2000 PMID： 11020288 DOI： 10.1021/jm000133v
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446